XML 218 R17.htm IDEA: XBRL DOCUMENT v3.22.0.1
Results for the Year (Details) - DKK (kr)
kr in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenue      
Revenue kr 8,482 kr 10,111 kr 5,366
Janssen      
Revenue      
Revenue 6,847 4,693 4,983
AbbVie      
Revenue      
Revenue 245 4,398  
Roche      
Revenue      
Revenue 603 305 7
Seagen      
Revenue      
Revenue 135 201 226
BioNTech      
Revenue      
Revenue 416 230 115
Novartis (Arzaerra/Ofatumumab)      
Revenue      
Revenue 236 212 23
Other collaboration partners      
Revenue      
Revenue   72 12
Royalties      
Revenue      
Revenue 6,977 4,741 3,155
Reimbursement income      
Revenue      
Revenue 531 431 342
Milestone payments      
Revenue      
Revenue 954 351 kr 1,869
License fees      
Revenue      
Revenue   kr 4,588  
Collaboration revenue      
Revenue      
Revenue kr 20